The neutrophil-lymphocyte ratio (NLR) may be used to predict the need to escalate early use of biologic therapy in some patients with RA, according to Australian researchers. The simple and inexpensive test can predict at baseline who would end up having worse outcomes a year down the track, according to their study carried out at ...
Neutrophil levels show which RA patients are destined to fail therapy
By Sunalie Silva
23 Jul 2019